Go Pro
→ Dr. Ron Paul Issues New Warning: “The Next Financial Crisis Is Here” (From Altimetry) (Ad)tc pixel Free GBIM Stock Alerts
OTCMKTS:GBIM

Globeimmune (GBIM) Stock Price, News & Analysis

Globeimmune logo
$0.0001 0.00 (0.00%)
As of 09/29/2026 03:48 PM Eastern
Compare

About Globeimmune Stock (OTCMKTS:GBIM)

View Price History Chart DataSkip Price History Chart
Advanced
1 Day 5 Days 30 Days 90 Days 1 Year
Advanced

Key Stats

Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.04
Volume
12,537 shs
Average Volume
3,775 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GlobeImmune, Inc. was a biotechnology company focused on developing therapeutic vaccines and immunotherapies for cancer and infectious diseases. The company’s platform, known as Tarmogens, was designed to stimulate targeted immune responses against disease-associated proteins.

GlobeImmune’s development programs included investigational treatments directed at cancer targets such as mutant RAS proteins and telomerase, as well as programs for chronic infectious diseases including hepatitis C and tuberculosis. Its products were in the research and clinical-development stages and were not established commercial therapies.

Based in Colorado, GlobeImmune conducted its activities primarily through research and clinical-development programs in the United States. Public information about the company’s current operating activities and leadership is limited; GlobeImmune was historically a development-stage biotechnology company whose programs and corporate status changed substantially after it discontinued or reassessed several clinical initiatives.

AI Generated. May Contain Errors.

Receive GBIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globeimmune and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GBIM Stock News Headlines

GlobeImmune Inc.
August 18, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/gbim/financials
GlobeImmune, Inc. (GBIM) - Yahoo Finance
June 27, 2025  |  sg.finance.yahoo.comhttps://sg.finance.yahoo.com/quote/GBIM/
"How Much Can I Actually Spend Each Year With $2.5M Saved?"
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you make with it. Using the 4% rule as a benchmark, that balance could translate to about $100,000 in year one, adjusted upward for inflation each year after. But the 4% rule has potential downsides and may not fit every portfolio. A financial advisor can help size and structure a retirement budget around your income sources, taxes, and goals. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors.tc pixel
September 30 at 1:00 AM  |  SmartAsset (Ad)
GlobeImmune, Inc. (GBIM)
October 20, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/GBIM/news/
BSPM Biostar Pharmaceuticals, Inc.
May 14, 2024  |  seekingalpha.comhttps://seekingalpha.com/symbol/BSPM
Bubang Co Ltd (014470)
July 18, 2023  |  investing.comhttps://www.investing.com/equities/bubang-co-ltd
Nihon Knowledge Co Ltd (5252)
July 18, 2023  |  investing.comhttps://www.investing.com/equities/nihon-knowledge
Nuvista Energy Breaks Below 200-Day Moving Average - Notable for NVA
April 21, 2023  |  nasdaq.comhttps://www.nasdaq.com/articles/nuvista-energy-breaks-below-200-day-moving-average-notable-for-nva-0
See More Headlines

GBIM Stock Analysis - Frequently Asked Questions

Globeimmune's stock was trading at $0.0001 at the beginning of 2026. Since then, GBIM stock has increased by 0.0% and is now trading at $0.0001.

Globeimmune, Inc. (OTCMKTS:GBIM) announced its quarterly earnings data on Thursday, May, 12th. The biopharmaceutical company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.12. The biopharmaceutical company earned $0.94 million during the quarter.

Shares of GBIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Globeimmune investors own include Novavax (NVAX), Premier Gold Mines (PG), Algonquin Power & Utilities (AQN), Nordic American Tankers (NAT), Petroleo Brasileiro S.A.- Petrobras (PBR).

Company Calendar

Last Earnings
5/12/2016
Today
9/30/2026
Fiscal Year End
12/31/2026
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:GBIM
Previous Symbol
NASDAQ:GBIM
CIK
1245104
Web
www.globeimmune.com
Phone
(720) 667-2300
Fax
303-625-2710
Employees
3
Year Founded
1995

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (OTCMKTS:GBIM) was last updated on 9/30/2026 by MarketBeat.com Staff.
From Our Partners
Dr. Ron Paul Issues New Warning: “The Next Financial Crisis Is Here”
Dr. Ron Paul warns a dangerous experiment is already underway in Washington, involving at least 27 billion dol...
Altimetry | Sponsoredtc pixel
A Little Known Explorer Sits Near Major Gold Deposits
Barrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...
Wall Street Logic | Sponsoredtc pixel
Trump Wants to Reprice America's Gold at Market Value
The US government still values its gold reserves at 42 dollars an ounce, a price Congress set in 1973. Gold tr...
Concord Gold Capital | Sponsoredtc pixel
This AI Stock Reminds One Analyst of Early Nvidia
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
Should You Convert a Traditional IRA to a Roth After 60?
Considering a Roth conversion after 60? The upside includes no income limits on conversions, potential tax-fre...
SmartAsset | Sponsoredtc pixel
I've seen this movie before (last time: 17,556%)
My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...
Crypto 101 Media | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel